Open Access

Cardiac troponin I elevation with supraventricular tachycardia: two case reports and review of the literature

  • Feng Xue1Email author,
  • Ting-Bo Jiang1,
  • Bin Jiang1,
  • Xu-Jie Cheng1,
  • Yong-Ming He1,
  • Xun Li1 and
  • Xiang-Jun Yang1
BMC Research Notes20147:136

DOI: 10.1186/1756-0500-7-136

Received: 19 September 2013

Accepted: 4 February 2014

Published: 11 March 2014

Abstract

Background

Although cardiac troponin I gives excellent accuracy in the identification of myocardial necrosis, it can also be elevated in a series of diseases other than acute coronary syndromes.

Case presentation

We present two cases of Chinese patients with a high serum troponin I level after an acute episode of paroxysmal supraventricular tachycardia with normal coronary arteries via angiography.

Conclusion

Abnormal troponin elevations can be seen in patients presenting with paroxysmal supraventricular tachycardia and angiographically-normal coronary arteries. Caution is advised with the use of invasive assessments such as coronary angiography in the differential diagnosis of patients with paroxysmal supraventricular tachycardia and elevated troponin levels.

Keywords

Cardiac troponin I Acute coronary syndromes Paroxysmal supraventricular tachycardia

Background

Cardiac troponin I (cTnI) is only detectable in adult cardiac tissue [1]. It is a sensitive and specific biomarker consistent with cardiac damage and plays a primordial role in the diagnosis of patients with acute coronary syndromes (ACS) [2]. A high cTnI level however is not synonymous to ACS [3]. Patients with normal coronary arteries may have elevated cTnI because of other diseases such as severe congestive heart failure, myocarditis, cerebrovascular accident, renal insufficiency and so on [4]. Since 2003 it has been reported that patients suffering from paroxysmal supraventricular tachycardia (PSVT) had elevated troponin levels [5]. Coronary angiography is often performed in some patients presenting with PSVT because they have chest pain and high troponin levels. Here, we report two cases of PSVT-induced elevations in cTnI in the absence of coronary artery disease.

Case presentation

Case 1

A 64-year-old Chinese male patient was admitted to our hospital because of chest pain and palpitation on April 14, 2012. The symptoms lasted for forty-five minutes and were relieved when he arrived at the hospital. He had no history of hypertension, diabetes mellitus or other heart diseases. The results of physical examination were normal. His electrocardiogram showed ST segment depression > 1.0 mm in leads V3-6 (Figure 1A). The echocardiogram showed no abnormal changes. The level of cTnI was 0.09 ng/ml (normal < 0.08 ng/ml). The next day this value was up to 0.52 ng/ml. On the third day the value was down to normal. He was diagnosed as ACS and treated with aspirin, clopidogrel, low molecular weight heparin, atorvastatin and so on. One week later the patient underwent a coronary angiography which did not show us any evidence for coronary artery obstruction (Figure 2A,B). During electrocardiogram monitoring transient supraventricular tachycardia was found. Then a transesophageal electrophysiological study was carried on him. A regular supraventricular tachycardia due to reentry within the atrioventricular node was induced and terminated (Figure 1B). At the 15th day of his hospitalization he underwent a successful radiofrequency ablation. Thus his diagnosis was revised as paroxysmal supraventricular tachycardia and he was discharged with no further treatments. During one-year follow-up he was well.
https://static-content.springer.com/image/art%3A10.1186%2F1756-0500-7-136/MediaObjects/13104_2013_Article_2711_Fig1_HTML.jpg
Figure 1

Electrocardiographic images: The electrocardiogram of case 1 on the admission (A); The result of a transesophageal electrophysiological study of case 1 (B); The result of a transesophageal electrophysiological study of case 2 (C). (EB: bipolar esophageal lead).

https://static-content.springer.com/image/art%3A10.1186%2F1756-0500-7-136/MediaObjects/13104_2013_Article_2711_Fig2_HTML.jpg
Figure 2

Angiographic images: The left coronary (A) and right coronary (B) of case 1; The left coronary (C) and right coronary (D) of case 2.

Case 2

A 66-year-old Chinese male patient with recurrent palpitation for more than ten years was hospitalized with chief complaint of chest pain and palpitation for eight hours on Feb 27, 2013. A minimal response to sublingual nitroglycerin was seen. There was no abnormal changes in the electrocardiogram and echocardiogram. The level of cTnI was 0.16 ng/ml on admission. Nine hours later the value was up to 2.28 ng/ml. He was also diagnosed as ACS and received the same medicine as the first case. On the second day after hospitalization he felt palpitation again. The electrocardiogram showed supraventricular tachycardia that was terminated by the transesophageal atrial pacing (Figure 1C). The esophageal electrocardiogram demonstrated that he had atrioventricular nodal reentrant tachycardia. In order to determine if he had coronary artery disease, we performed a coronary angiography on this patient on Mar 1, 2013. Cardiac catheterization demonstrated normal coronary arteries (Figure 2C,D). After undergoing a radiofrequency ablation he was discharged from our hospital. As of the time of this writing he has no sympotoms.

Discussion

Paroxysmal supraventricular tachycardia is a common and generally benign arrhythmia. It rarely results in any adverse clinical outcomes. But it was reported that 30% of patients presenting with PSVT had significant troponin elevations [6]. Because these patients had symptoms of chest pain and chest discomfort they were often misdiagnosed as ACS and given inappropriate treatments such as antiplatelet and antithrombotic therapy. Coronary angiography however revealed that most of them had normal coronary arteries. The mechanism of tachycardia-induced troponin elevation is not fully understood [6]. Most authors are in agreement with the mechanism that tachycardia increases myocardial oxygen demand, while it decreases myocardial oxygen delivery because of short diastole during which myocardial perfusion occurs. So tachycardia ultimately leads to reduced myocardial perfusion which results in the release of cTnI into the circulation [4].

What are the characteristics of patients with elevated troponins due to PSVT? We reviewed the English-language scientific literature from the MEDLINE and ELSEVIER databases using the keywords “troponin” and“PSVT”. Most authors found that patients with elevated troponins after acute attack of PSVT were not at increased cardiovascular risk such as hypertension, diabetes or dyslipidemia [6]. This agrees with our cases. They also believed that the duration of arrhythmia was not associated with troponin elevation [7]. However, the maximal PSVT heart rate, ST-segment depression ≥1 mm during the episode of PSVT and the presence of impaired left ventricular systolic function were correlated with troponin elevation [6, 8].

Is coronary angiography necessary to be carried out in these patients with PSVT which resulted in elevated troponins? Dorenkamp’s study replied this question [9]. In their retrospective analysis troponin levels were increased in 14 of 114 patients. Thirteen of the 14 patients were subjected to coronary angiography. The result was that no one had significant coronary stenosis. They found a positive exercise test was the best predictor of significant coronary artery disease and subsequent revascularization. A history of hypertension and age 60 years or more ranked secondly. So when we confronted a patient with PSVT and elevated troponin, we should pay attention to his medical history including cardiac risk factors and age. Then a noninvasive assessment for coronary stenosis such as the exercise test can be chosen before coronary angiography. This was not implemented well in clinical practice according to our cases and other reports.

What is prognostic significance of elevated troponins in these patients with PSVT? This question has different answers. Calberg and his colleagues made a retrospective review of 51 patients with PSVT, 38 of whom had cTnI value meassured at least one time [4]. Eleven patients having elevated cTnI were followed up for thirty days. They found that none of patients had adverse cardiovascular outcomes. On the contrary, Chow and his colleagues’ research drew the conclusion that mild cTnI elevation in patients with PSVT was associated with increased risk of future cardiovascular events such as death, myocardial infarction or cardiovascular rehospitalization [8]. They studied 78 patients including 29 patients with elevated cTnI. The mean follow-up period was 2.2 ± 1.7 years. These two retrospective studies had a common limitation that the numbers of patients were too small for analysis. Both prospective observational studies and larger retrospective studies are recommended to answer this question.

Conclusions

Abnormal troponin elevations can be seen in patients presenting with PSVT and angiographically normal coronary arteries. Patients can not be diagnosed as ACS only because they have elevated troponins. Caution is advised with the use of invasive assessments such as coronary angiography in the differential diagnosis of patients with PSVT and elevated troponins.

Consent

Written informed consent was obtained from both patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Authors’ information

All authors are staff members of the Department of Cardiology, First Affiliated Hospital of Soochow University, Suzhou, 215006, China.

Abbreviations

CTnI: 

Cardiac troponin I

ACS: 

Acute coronary syndromes

PSVT: 

Paroxysmal supraventricular tachycardia.

Declarations

Authors’ Affiliations

(1)
Department of Cardiology, First Affiliated Hospital of Soochow University

References

  1. Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, Gaze D, Thompson PD: Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010, 56: 169-176. 10.1016/j.jacc.2010.03.037.PubMedView ArticleGoogle Scholar
  2. Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, Fesmire FM, Geraci SA, Gersh BJ, Larsen GC, Kaul S, McKay CR, Philippides GJ, Weintraub WS: ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2012, 60: 2427-2463. 10.1016/j.jacc.2012.08.969.PubMedView ArticleGoogle Scholar
  3. Mahajan N, Mehta Y, Rose M, Shani J, Lichstein E: Elevated troponin level is not synonymous with myocardial infarction. Int J Cardiol. 2006, 111: 442-449. 10.1016/j.ijcard.2005.08.029.PubMedView ArticleGoogle Scholar
  4. Carlberg DJ, Tsuchitani S, Barlotta KS, Brady WJ: Serum troponin testing in patients with paroxysmal supraventricular tachycardia: outcome after ED care. Am J Emerg Med. 2011, 29: 545-548. 10.1016/j.ajem.2010.01.041.PubMedView ArticleGoogle Scholar
  5. Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S: Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med Wkly. 2003, 33: 439-441.Google Scholar
  6. Ben Yedder N, Roux JF, Paredes FA: Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol. 2011, 27: 105-109. 10.1016/j.cjca.2010.12.004.PubMedView ArticleGoogle Scholar
  7. Redfearn DP, Ratib K, Marshall HJ, Griffith MJ: Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. Int J Cardiol. 2005, 102: 521-522. 10.1016/j.ijcard.2004.05.076.PubMedView ArticleGoogle Scholar
  8. Chow GV, Hirsch GA, Spragg DD, Cai JX, Cheng A, Ziegelstein RC, Marine JE: Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia. Medicine (Baltimore). 2010, 89: 141-148. 10.1097/MD.0b013e3181dddb3b.View ArticleGoogle Scholar
  9. Dorenkamp M, Zabel M, Sticheling C: Role of coronary angiography before radiofrequency ablation in patients presenting with paroxysmal supraventricular tachycardia. J Cardiovasc Pharmacol Ther. 2007, 12: 137-144. 10.1177/1074248407300775.PubMedView ArticleGoogle Scholar

Copyright

© xue et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.